Antimicrobial Susceptibility Testing Market Report
First published: 07 October 2024 | Last updated: 25 May 2026 | Report Code: antimicrobial-susceptibility-testing
Antimicrobial Susceptibility Testing Market — USD 2.5 billion in 2023, Growing to USD 4.91B by 2033 at 6.8% CAGR
This report provides a comprehensive analysis of the Antimicrobial Susceptibility Testing market, focusing on market dynamics, trends, regional insights, and future forecasts between 2023 and 2033.
Key Takeaways
- Global market expands from $2.50 Billion in 2023 to $4.91 Billion in 2033 at a 6.8% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Regional growth mirrored across Europe ($0.64B to $1.26B) and Asia Pacific ($0.49B to $0.97B) through 2033.
- Automation, consumables and molecular approaches figure prominently among product and methodology shifts.
- Major industry participants include BioMerieux, Thermo Fisher Scientific, Becton Dickinson and Cepheid.
Antimicrobial Susceptibility Testing Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report outlines market dynamics for antimicrobial susceptibility testing from 2023 to 2033, with the global market rising from $2.50 Billion to $4.91 Billion at a 6.8% CAGR. Growth is supported by rising clinical demand for accurate susceptibility data, technological shifts toward automated platforms, and expanding diagnostic investment in healthcare systems. The analysis covers product types, methodologies, end users and regional performance, highlighting North America as the largest regional market (from $0.83 Billion to $1.64 Billion). It also profiles leading firms such as BioMerieux, Thermo Fisher Scientific, Becton Dickinson and Cepheid, and summarizes primary trends and market segmentation to guide stakeholders on adoption drivers and opportunity areas.
Key Growth Drivers
- Increasing need for precise antibiotic susceptibility information in clinical decision-making.
- Adoption of automated testing platforms and digital workflows that improve throughput and consistency.
- Rising healthcare spending and investment in diagnostic infrastructure across multiple regions.
- Ongoing research and product development by leading firms expanding test capabilities and consumable demand.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $4.91 Billion |
| Top Companies | BioMerieux, Thermo Fisher Scientific, Becton Dickinson, Cepheid |
| Published Date | 07 October 2024 |
| Last Modified Date | 25 May 2026 |
Antimicrobial Susceptibility Testing Market Overview
Customize Antimicrobial Susceptibility Testing Market Report market research report
- ✔ Get in-depth analysis of Antimicrobial Susceptibility Testing market size, growth, and forecasts.
- ✔ Understand Antimicrobial Susceptibility Testing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Antimicrobial Susceptibility Testing
What is the Market Size & CAGR of Antimicrobial Susceptibility Testing Market Report market in 2023?
Antimicrobial Susceptibility Testing Industry Analysis
Antimicrobial Susceptibility Testing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Antimicrobial Susceptibility Testing Market Report Market Analysis Report by Region
Europe Antimicrobial Susceptibility Testing Market Report:
Europe grows from $0.64 Billion in 2023 to $1.26 Billion in 2033. This expansion aligns with investments in diagnostic accuracy, evolving laboratory workflows and interest in integrated testing approaches that address antimicrobial resistance challenges.Asia Pacific Antimicrobial Susceptibility Testing Market Report:
Asia Pacific grows from $0.49 Billion in 2023 to $0.97 Billion in 2033. Growth is influenced by expanding healthcare infrastructure, rising diagnostic capacity and gradual adoption of automated and molecular testing solutions.North America Antimicrobial Susceptibility Testing Market Report:
North America is largest regional market, rising from $0.83 Billion in 2023 to $1.64 Billion in 2033. Regional scale reflects higher diagnostic spending, established laboratory networks and adoption of automated testing systems driving demand for instruments and consumables.South America Antimicrobial Susceptibility Testing Market Report:
Latin America grows from $0.21 Billion in 2023 to $0.42 Billion in 2033. Regional development reflects growing clinical testing needs and incremental investment in laboratory equipment, consumables and diagnostic services.Middle East & Africa Antimicrobial Susceptibility Testing Market Report:
Middle East and Africa grows from $0.32 Billion in 2023 to $0.63 Billion in 2033. Demand is supported by expanding healthcare access, increased focus on infection control and gradual modernization of diagnostic laboratories.Tell us your focus area and get a customized research report.
Research Methodology
Antimicrobial Susceptibility Testing Market Analysis By Product Type
In 2023, the product types like Broth Micro-dilution and Automated Systems accounted for significant shares. Broth Micro-dilution is expected to hold a dominant market share of approximately 64.16% in 2023, while Automated Systems are anticipated to grow from $0.58 billion to $1.15 billion by 2033.
Antimicrobial Susceptibility Testing Market Analysis By Methodology
Broth micro-dilution techniques lead the AST methodologies held an expected market share of 64.16% in 2023. Agar diffusion techniques followed with 23.34% of the market share, showcasing their critical role in susceptibility testing for clinical settings.
Antimicrobial Susceptibility Testing Market Analysis By Organism Type
The bacteria segment dominates the market, holding a significant 64.16% well into the forecasted period. The fungi and viruses segments are also growing but have smaller market shares of 23.34% and 12.5% respectively.
Antimicrobial Susceptibility Testing Market Analysis By End User
Hospitals lead this segment with a market share of 55.57% in 2023, expected to maintain steady growth due to the high patient turnover and sheer volume in diagnostic testing. Diagnostic laboratories and research institutes follow closely with shares of 24.52% and 9.98%, respectively.
Antimicrobial Susceptibility Testing Market Analysis By Region
Geographically, North America has a commanding presence, while regions like Asia Pacific are expected to witness rapid growth, attributed to increasing healthcare investments and rising awareness of antimicrobial resistance. Europe remains strong due to regulatory requirements for high standards in testing.
Antimicrobial Susceptibility Testing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Antimicrobial Susceptibility Testing Industry
BioMerieux:
A leading company specializing in the development of microbiological tools, BioMerieux delivers robust solutions for Infectious Disease testing and is well-known for its advanced AST products.Thermo Fisher Scientific:
Known for cutting-edge technology, Thermo Fisher provides a range of AST solutions, innovative products, and advanced laboratory services, aiding in combating antimicrobial resistance.Becton Dickinson:
Becton Dickinson's comprehensive product line in Diagnostic tools makes it a crucial player in the market, focusing on enhancing patient and laboratory outcomes in susceptibility testing.Cepheid:
Cepheid is renowned for its automated molecular testing, and offers groundbreaking solutions in rapid diagnostic testing, impacting significantly on antibiotic susceptibility testing.We're grateful to work with incredible clients.
FAQs
What is the market size of the Antimicrobial Susceptibility Testing Market Report in 2023?
The market size in 2023 is $2.50 Billion, as stated in the report's base-year figures.
How big will the Antimicrobial Susceptibility Testing Market Report be in 2033?
By 2033 the market is projected to reach $4.91 Billion according to the provided forecast.
What is CAGR for the Antimicrobial Susceptibility Testing Market Report during the forecast period?
The forecast period 2023 to 2033 has an exact CAGR of 6.8% as provided in the inputs.
Is there a single fastest Growing region in the Antimicrobial Susceptibility Testing Market Report market?
No single fastest-growing region is stated for the Antimicrobial Susceptibility Testing Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top players?
Top companies specified include BioMerieux, Thermo Fisher Scientific, Becton Dickinson and Cepheid.
What are primary methodological segments reported?
Methodology sub segments listed are Broth Micro-dilution, Agar Diffusion and Epidemiological Susceptibility Testing.
Who are the typical end users for antimicrobial susceptibility testing?
End-user segments include Hospitals, Diagnostic Laboratories, Research Institutes and Pharmaceutical Companies as specified.
How is regional growth described in the report?
Regional facts present explicit start and end values for each region and note that no single regional growth market is named.